Chromium
Best-in-class: Chromium Picolinate
A trace mineral that enhances insulin's action on cells, studied for glucose control and carbohydrate cravings.
Chromium quick facts
| Suggested dose | 200–1,000 mcg daily with meals. |
| How often | daily |
| Who it's for | Blood-sugar support and craving management. |
Oversold for years as a fat-loss supplement, and meta-analyses do not support that use. Where it does look reasonable is insulin sensitivity in people with low intake or type-2 diabetes, and there is some signal for reduced carbohydrate cravings. The effect size is modest. It is cheap and safe at ordinary doses, which is the honest argument for trying it rather than any dramatic data.
How Chromium actually works
Chromium is a component of chromodulin, a small oligopeptide that binds to the activated insulin receptor and amplifies its tyrosine kinase activity — so the same amount of insulin produces a larger downstream signal. Picolinate is the chelate with the best absorption of the common forms. The size of this effect in a replete person is contested, and chromium's status as a genuinely essential nutrient has been questioned in the last decade.
Where to get Chromium
Buy Chromium Picolinate at Thorne →The evidence for Chromium
Graded by what exists behind each claim.
✅ Clinically validated
- Meta-analyses show modest improvement in glycemic control in type-2 diabetes.
- Some RCT support for reduced carbohydrate cravings and appetite.
📊 Correlative data
- Low chromium status is associated with impaired glucose tolerance.
🧪 Theoretical / extrapolated benefits
- Body-composition and weight-loss claims exceed the modest human data.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Chromium actually does
Chromium is the one mineral in this catalog whose essentiality is actively disputed, and the page has to start there rather than with a mechanism. No chromium-dependent enzyme has been isolated in humans, no deficiency syndrome has been reproduced experimentally, and the scoping review prepared for national nutrition recommendations treats the evidence for a human requirement as insufficient rather than established Henriksen 2023. European authorities have withdrawn the adequate intake figure on that basis.
The mechanism the whole category was built on was a molecule that turned out not to be what was described. Glucose tolerance factor, isolated from brewer's yeast in the 1950s and characterized as a chromium-nicotinic acid-amino acid complex, was the original rationale. It has never been definitively purified or synthesized as described, and the field largely abandoned it.
Its successor is chromodulin, and the evidence for it is better and still thin. Chromodulin, also called the low-molecular-weight chromium-binding substance, is an oligopeptide proposed to bind four chromic ions and to amplify insulin receptor tyrosine kinase activity after insulin binding. That is a specific, testable mechanism; the human evidence that it operates at physiological chromium status is what is missing.
The proposed downstream effect is amplification rather than signaling. If chromodulin works as described, chromium does not initiate insulin signaling but increases the gain on it, which predicts an effect only where insulin signaling is already impaired and none where it is normal. That prediction matches the shape of the trial literature better than the marketing does Fong 2022.
And the oxidation state matters more than any of this. Trivalent chromium is the dietary and supplemental form, poorly absorbed and rapidly excreted. Hexavalent chromium is an industrial oxidant, a class 1 carcinogen, and enters cells through sulfate transporters before being reduced intracellularly with genotoxic intermediates. They share a name and nothing else Pereira 2021.
Cell, rodent, human — and where it stops
The marker is HbA1c, it moves a little in some trials, and the evidence synthesis that graded the whole field put it near the bottom.
The essentiality question was never settled in humans. The original evidence was a small number of patients on long-term parenteral nutrition whose glucose intolerance improved on chromium, and those cases have been reinterpreted since. The scoping review reflects that unsettled state Henriksen 2023.
In type 2 diabetes the trials exist and the synthesis is unimpressed. An umbrella review and hierarchical evidence synthesis of nutrient supplements for glycemic control and insulin resistance grades the certainty of the evidence rather than just pooling effect sizes, and chromium does not emerge as a well-supported intervention Fong 2022. That is a stricter and more useful assessment than a single meta-analysis.
The obstacle to transfer is that the trials cannot select responders. If chromodulin amplifies insulin signaling, the responders would be people with both impaired insulin sensitivity and low chromium status. There is no test for the second, so every trial enrolls unselected people and dilutes any real effect Henriksen 2023.
The delivered dose is also uncertain, and somebody measured that. An in vitro evaluation of chromium bioavailability from daily food rations and from dietary supplements found that what a label declares and what is released differ, which is an unusual and welcome study to have Bawiec 2024. Absorption of trivalent chromium is on the order of 0.5 to 2 percent in any case.
The claims outside glycemia are weaker still. Chromium and selenium have been reviewed for psychiatric symptoms with the evidence described as potential rather than established Di Lisi 2025, and the reproductive literature for chromium picolinate is animal and mechanistic Moreira 2023. The weight-loss claim, which is what most chromium picolinate is bought for, rests on trials whose pooled effect is under a kilogram.
Chromium — which form, and does it matter
Picolinate is not a delivery vehicle, it is a co-administered chelator with its own biology. Chromium picolinate pairs a chromic ion with three picolinic acid molecules; the complex is more lipophilic than chromium chloride and is absorbed severalfold better, which is why it dominates the market. Picolinic acid is also a tryptophan metabolite and a metal chelator in its own right, and the toxicology questions raised about this supplement attach to the ligand rather than to the metal Moreira 2023.
The other forms differ mainly in how little is absorbed. Chromium chloride is absorbed at well under 1 percent; chromium nicotinate and the nicotinate-glycinate chelates fall in between; chromium-enriched yeast delivers chromium in an organic matrix whose release has been measured directly against supplements Bawiec 2024.
The exposure numbers explain why the dose is measured in hundreds of micrograms. Absorption of trivalent chromium is 0.5 to 2 percent and falls as intake rises; peak plasma concentration arrives within a couple of hours; and the absorbed fraction is bound to transferrin, distributed, and then cleared almost entirely by renal clearance with more than 80 percent of the absorbed dose appearing in urine. There is no cytochrome metabolism and no first-pass hepatic extraction — chromium is not transformed, it is transported and excreted Henriksen 2023.
Iron competes for the carrier, which is a real interaction hiding in plain sight. Chromium and iron both bind transferrin, so high iron status reduces chromium transport and chronic high-dose chromium has been raised as a theoretical competitor for iron binding. That is one of the few chromium interactions with a mechanism.
What the panel in front of this reader contains. The Trace Minerals product filed in the NIH label database declares 100 micrograms of chromium as a nicotinate-glycinate chelate per capsule Office of Dietary Supplements, against standalone picolinate products at 200 to 1,000 micrograms. Those are different ligands at up to a tenfold difference in dose, and the trial literature is almost entirely picolinate.
What would have to be true, and how you would know it was not
1. Predict there is nothing useful to measure. Predict that no clinically available test reports chromium status; serum and urinary chromium reflect recent intake and contamination as much as anything else, and hair chromium is unvalidated Henriksen 2023. That absence is the reason no trial can select responders.
2. Predict the glycemic markers move a little, if at all, and only where they were abnormal. Predict a small change in HbA1c (hemoglobin A1c) and fasting insulin at 12 weeks in someone with type 2 diabetes and none in a person with normal glucose Fong 2022. Retest at 12 weeks, since HbA1c reflects the preceding three months.
3. The prediction that cuts against the product. Predict no meaningful weight change on 200 to 1,000 micrograms a day over 12 weeks, and predict that any pooled effect is under a kilogram and within the noise of a diet record Fong 2022. A well-powered trial showing a clinically meaningful weight or HbA1c effect would falsify this page.
4. Predict the ligand, not the metal, is where a toxicology question would appear. Predict that any adverse signal attaches to picolinic acid rather than to chromium, because picolinate is the component with the chelating chemistry and the reproductive literature Moreira 2023. A trial comparing chromium picolinate with an equivalent chromium dose as chloride would separate them and has not been run.
5. Predict the psychiatric claim needs a proper trial before it needs a dose. Predict that the reported effects on mood and carbohydrate craving do not survive an adequately powered blinded trial, on the basis that the current reviews describe potential rather than demonstrated benefit Di Lisi 2025.
What nobody has tested yet
Whether chromium is essential for humans is unresolved and it is the first question. No enzyme, no reproducible deficiency, and a withdrawn adequate intake in one major jurisdiction Henriksen 2023. Everything else on this page is downstream of that unanswered question.
Chromodulin has never been demonstrated to operate at physiological status in a person. The oligopeptide and its proposed amplification of insulin receptor kinase activity are characterized biochemically and have never been shown to be chromium-limited in a human. That is the experiment the field needs.
The picolinate-versus-chromium question has never been separated. Almost every trial used picolinate, and the ligand has its own chelating and metabolic activity Moreira 2023 Pereira 2021. A head-to-head against an equimolar chromium salt would tell the field whether it has been studying a mineral or a picolinate.
And what is actually released from a supplement is barely studied. One in vitro evaluation of bioavailability from food rations and market supplements Bawiec 2024 is close to the whole literature on that question. For a product bought in the millions, that is a thin foundation.
Chromium — its own safety story, not its category's
Trivalent chromium at supplemental doses has a good tolerability record, and the absence of a tolerable upper intake level reflects insufficient data rather than demonstrated safety. Headache, mood change and gastrointestinal upset are the usual reports Henriksen 2023.
The isolated serious reports involve kidney and liver and are rare. Case reports of acute kidney injury, rhabdomyolysis and hepatic dysfunction have been published in people taking chromium picolinate at high doses for months. The causal attribution in each is uncertain and the pattern is consistent enough to be worth naming for anybody taking a gram-scale microgram dose long term.
The in vitro genotoxicity signal belongs to the picolinate complex. Chromium picolinate has produced chromosomal damage in some cell systems where chromium chloride did not, which points at the ligand and at the redox chemistry the complex permits Moreira 2023. That has not been demonstrated to matter in people, and it is the reason the ligand question above is a safety question rather than a pharmacology one.
The additive effect is glycemic and it matters most in the population that buys it. Anyone on insulin or a sulfonylurea taking chromium for glucose control is combining two hypoglycemic interventions Fong 2022, and glucose monitoring for the first weeks is the sensible handling.
Who should be careful, and one clarification worth making. Anyone with reduced kidney function, since clearance is renal; anyone with liver disease; and anyone pregnant, where supplemental doses have no adequate data. And nothing on this page concerns hexavalent chromium, which is an industrial carcinogen and is not what is in a supplement Pereira 2021. Nothing here is medical advice or diagnosis, and these statements have not been evaluated by the Food and Drug Administration.
Sources read for this page
- Henriksen C. Chromium - a scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res 2023 · PMID 38084146
- Fong C. Efficacy and Safety of Nutrient Supplements for Glycemic Control and Insulin Resistance in Type 2 Diabetes: An Umbrella Review and Hierarchical Evidence Synthesis. Nutrients 2022 · PMID 35684094
- Bawiec P. In Vitro Evaluation of Bioavailability of Cr from Daily Food Rations and Dietary Supplements from the Polish Market. Nutrients 2024 · PMID 38613055
- Moreira R. A Comprehensive Review of the Impact of Chromium Picolinate on Testicular Steroidogenesis and Antioxidant Balance. Antioxidants (Basel) 2023 · PMID 37627567
- Pereira SC. Impact of Environmental and Lifestyle Use of Chromium on Male Fertility: Focus on Antioxidant Activity and Oxidative Stress. Antioxidants (Basel) 2021 · PMID 34572997
- Di Lisi A. The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms. J Clin Psychopharmacol 2025 · PMID 40345207
- Office of Dietary Supplements, National Institutes of Health. Trace Minerals (Thorne) -- filed Supplement Facts panel: per capsule, zinc 15 mg, selenium 100 mcg, manganese 2.5 mg, chromium 100 mcg, boron 700 mcg; no copper, no molybdenum, no iodine; off market as of 22 October 2024. NIH Dietary Supplement Label Database, DSLD ID 291799
How you would know if it worked
These are the markers that recommend this product on their own pages, so they are the ones that should move if it is doing what it is sold for.
- Fasting Insulin Retest: Every 3–6 months, or 8–12 weeks after an intervention.
- HbA1c (Hemoglobin A1c) — Berberine, myo-inositol, magnesium, chromium, alpha-lipoic acid, cinnamon (modest) Retest: Every 3 months (matches red cell lifespan).
- Fructosamine — Berberine, inositol, magnesium, chromium Retest: Every 3–4 weeks during active intervention.
The cheapest panel carrying Fasting Insulin and at least one other of these is Am I Prediabetic?, at $19 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Chromium — safety & side effects
- Well tolerated. Headache, mood change and GI upset are the usual reports.
- Lowers blood glucose — additive with insulin and sulfonylureas, and worth monitoring if you are medicated for diabetes.
- Rare reports of kidney and liver injury at high doses over long periods, mostly with chromium picolinate. Avoid with kidney disease.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Chromium in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Chromium
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| HbA1c (Hemoglobin A1c) | The glucose claim, measured over three months |
| Fasting Insulin | Where any real effect would appear first |
| Comprehensive Metabolic Panel (CMP) | Fasting glucose and kidney function |
The Metabolic Health & Prediabetes panel covers these in one order — 8 markers, $81.45 with the discount applied.
Check results you already have → · All 103 markers A–Z
Chromium — frequently asked questions
What is Chromium?
A trace mineral that enhances insulin's action on cells, studied for glucose control and carbohydrate cravings.
What is the suggested dose of Chromium?
200–1,000 mcg daily with meals. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Chromium dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Chromium?
Coach Cam sources Chromium from Thorne, with 10% off auto-applied at checkout — use the buy link on this page.
Chromium inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Chromium is used for
Chromium appears under 4 goals in the goal router.
Related Minerals supplements
Where this goes next
Chromium is the insulin-sensitivity arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.